Table 1 Baseline characteristics of patients with prostate cancer undergoing HoLEP, ThuLEP, and TURP.
Characteristic | HoLEP, n = 8160 | ThuLEP, n = 2285 | TURP, n = 211,323 |
|---|---|---|---|
Age (years) | 75 (69–80) | 75 (69–80) | 76 (70–81) |
Diabetes | 1475 (18%) | 407 (18%) | 41,353 (20%) |
Chronic heart failure | 315 (3.9%) | 79 (3.5%) | 13,748 (6.5%) |
COPD | 443 (5.4%) | 145 (6.3%) | 15,086 (7.1%) |
Chronic kidney disease | 548 (6.7%) | 155 (6.8%) | 26,516 (13%) |
Hypertension | 10,554 (51%) | 1256 (55%) | 118,194 (56%) |
Obesity | 299 (3.7%) | 115 (5.0%) | 11,477 (5.4%) |
Year of surgery | |||
2012 | 259 (3.2%) | 0 | 12,104 (5.7%) |
2013 | 345 (4.2%) | 0 | 11,376 (5.4%) |
2014 | 372 (4.6%) | 0 | 11,448 (5.4%) |
2015 | 426 (5.2%) | 0 | 11,537 (5.5%) |
2016 | 611 (7.5%) | 0 | 11,479 (5.4%) |
2017 | 694 (8.5%) | 0 | 11,690 (5.5%) |
2018 | 735 (9.0%) | 387 (17%) | 11,680 (5.5%) |
2019 | 975 (12%) | 426 (19%) | 11,561 (5.5%) |
2020 | 1068 (13%) | 403 (18%) | 10,274 (4.9%) |
2021 | 1266 (16%) | 464 (20%) | 10,229 (4.8%) |
2022 | 1409 (17%) | 605 (26%) | 10,194 (4.8%) |
